CN Stock MarketDetailed Quotes

000963 Huadong Medicine

Watchlist

40.05 -0.24-0.60%

Market Closed 09/22 15:00 CST

40.50High39.50Low125.85KlotVolume

Huadong Medicine Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)2023/06/30

(Q3)2023/03/31

(FY)2022/12/31

(Q9)2022/09/30

(Q6)2022/06/30

(Q3)2022/03/31

(FY)2021/12/31

(Q9)2021/09/30

(Q6)2021/06/30

(Q3)2021/03/31

Assets

Current assets

Money funds

19.30%4.39B

-27.52%2.38B

-0.90%4B

-5.69%3.18B

12.65%3.68B

4.71%3.28B

26.09%4.03B

31.30%3.37B

32.36%3.27B

15.69%3.13B

Notes receivable and accounts receivable

-0.78%7.4B

4.43%8.64B

12.08%7.21B

8.39%8.83B

8.48%7.45B

7.07%8.28B

4.77%6.43B

4.62%8.15B

5.95%6.87B

8.93%7.73B

-Notes receivable

----

--8.42M

----

-Accounts receivable

-0.78%7.4B

4.33%8.63B

11.95%7.2B

8.39%8.83B

8.48%7.45B

7.07%8.28B

4.77%6.43B

4.62%8.15B

5.95%6.87B

8.93%7.73B

Other receivables (including interest and dividends)

42.86%553.68M

17.80%426.38M

26.82%283.71M

23.97%371.53M

237.90%387.57M

199.12%361.94M

156.34%223.71M

47.92%299.69M

-5.85%114.7M

59.74%121M

-Dividend receivable

-93.43%223.75K

-74.51%223.75K

309.11%3.4M

-79.08%877.73K

2.00%832.29K

414.20%4.2M

-Accrued interest receivable

----

--15.97M

--6.33M

----

-Other receivable

44.07%553.46M

----

27.22%283.49M

----

257.23%384.16M

----

168.23%222.83M

--282.88M

-11.13%107.54M

----

Advance payment

57.66%362.09M

56.12%558.91M

81.62%500.08M

-1.90%286.05M

7.61%229.66M

0.53%358.01M

13.17%275.35M

-30.61%291.58M

-52.33%213.42M

7.17%356.12M

Inventories

14.86%4.6B

29.00%5.06B

13.11%4.5B

-0.68%4.1B

-3.04%4B

-6.35%3.92B

-2.29%3.97B

5.49%4.13B

17.08%4.13B

3.69%4.18B

Receivable financing

67.47%1.34B

104.45%1.07B

96.88%1B

-11.69%505.22M

51.33%802.25M

-9.29%524.34M

-38.55%509.19M

-32.25%572.08M

-56.68%530.12M

-54.91%578.07M

Other current assets

34.40%54.88M

341.15%154.24M

28.81%52.69M

32.19%50.28M

-9.11%40.84M

-31.72%34.96M

-52.24%40.91M

22.82%38.04M

133.99%44.93M

-28.58%51.2M

Total current assets

12.81%18.73B

9.33%18.31B

13.44%17.57B

2.82%17.32B

9.41%16.6B

3.72%16.75B

5.72%15.49B

6.85%16.85B

6.14%15.17B

3.54%16.15B

Non Current assets

Other equity investment

63.42%409.85M

62.83%409.91M

39.99%360.91M

177.03%359.7M

6.38%250.79M

10.14%251.73M

14.35%257.82M

-47.54%129.84M

-2.54%235.76M

-4.88%228.57M

Investment real estate

-6.48%13.17M

-6.41%13.39M

-6.32%13.65M

-18.92%13.85M

-18.05%14.09M

-18.37%14.31M

-18.12%14.57M

-15.78%17.08M

-18.91%17.19M

-18.35%17.53M

Long-term equity investment

54.56%1.55B

61.66%1.62B

68.45%1.66B

78.18%1.69B

6.19%1.01B

5.84%999.35M

15.86%984.93M

53.86%950.89M

125.99%947.01M

190.58%944.23M

Fixed assets

29.12%3.88B

----

29.39%3.98B

----

12.66%3.01B

----

27.14%3.08B

----

24.43%2.67B

----

Constru in process

-43.33%995.49M

----

-44.81%873.16M

----

-12.18%1.76B

----

-29.38%1.58B

----

-3.76%2B

----

Intangible assets

3.20%2.34B

1.09%2.25B

2.09%2.28B

31.53%2.25B

37.55%2.26B

55.15%2.23B

52.64%2.23B

17.90%1.71B

10.34%1.65B

4.61%1.43B

Development expenditure

2,068.06%774.1M

--689.29M

--641.35M

--108M

--35.7M

----

Goodwill

16.13%2.59B

14.83%2.46B

14.15%2.44B

18.04%2.48B

6.09%2.23B

45.54%2.14B

42.90%2.1B

0.00%1.47B

Long deferred expense

85.09%20.98M

54.11%20.51M

32.45%16.46M

33.11%13.99M

2.65%11.34M

69.46%13.31M

43.06%12.43M

14.96%10.51M

11.18%11.04M

-31.55%7.86M

Deferred tax assets

22.06%192.39M

6.77%153.37M

6.40%152.84M

4.03%157.61M

4.22%143.65M

15.66%151.51M

18.66%137.83M

Usufruct assets

10.69%140.46M

2.20%146.53M

8.31%166.51M

-29.47%113.95M

-1.58%126.89M

-6.15%143.37M

-19.82%153.72M

--161.57M

--128.93M

--152.76M

Other non current assets

1.46%1.32B

12.41%1.2B

13.85%1.04B

119.00%1.41B

26.65%1.3B

14.56%1.07B

27.95%911.06M

24.47%642.49M

415.64%1.03B

293.35%931.65M

Total non current assets

17.01%14.23B

18.10%13.8B

18.37%13.62B

23.05%13.34B

11.20%12.16B

17.48%11.68B

18.21%11.51B

25.28%10.84B

33.23%10.93B

25.45%9.95B

Total assets

14.59%32.96B

12.93%32.12B

15.54%31.19B

10.74%30.66B

10.16%28.76B

8.97%28.44B

10.71%27B

13.38%27.69B

16.02%26.11B

10.92%26.1B

Liabilities

Current liabilities

Short term loan

22.53%1.05B

-24.91%563.01M

-23.45%947.52M

-42.51%736.19M

-38.06%858.69M

-49.59%749.83M

-12.64%1.24B

-6.39%1.28B

1.77%1.39B

84.79%1.49B

Transactional financial liabilities

--8.97M

--14.84M

----

Notes payable and accounts payable

28.86%6.45B

22.82%6.35B

30.59%5.9B

3.99%5.9B

0.08%5B

3.21%5.17B

0.41%4.52B

13.43%5.67B

20.98%5B

12.27%5.01B

-Notes payable

95.44%1.73B

9.57%1.36B

53.19%1.03B

-14.68%1.18B

-9.75%884.31M

26.52%1.24B

21.22%671.96M

163.74%1.38B

131.90%979.86M

44.26%981.41M

-Accounts payable

14.57%4.72B

27.01%4.99B

26.65%4.87B

9.99%4.72B

2.48%4.12B

-2.46%3.93B

-2.52%3.85B

-4.15%4.29B

8.35%4.02B

6.52%4.03B

Contract liabilities

112.06%125.33M

48.34%192.64M

23.78%146.49M

-25.32%139.27M

9.61%59.1M

-21.36%129.86M

25.38%118.34M

58.36%186.49M

-0.39%53.92M

--165.14M

Advance receipts

-4.09%1.87M

-24.34%881.24K

0.59%1.15M

-0.07%1.9M

-2.70%1.95M

70.20%1.16M

20.54%1.15M

-88.76%1.91M

24.01%2M

-98.34%684.38K

Salaries payable

11.47%215.06M

34.34%175.67M

52.72%256.88M

31.58%211.13M

64.97%192.93M

6.87%130.76M

10.59%168.21M

-18.60%160.46M

-32.70%116.95M

-18.49%122.36M

Taxs payable

-39.23%335.3M

-58.74%479.79M

-58.29%429.46M

10.88%626.83M

-11.50%551.79M

67.59%1.16B

80.07%1.03B

6.76%565.34M

73.45%623.46M

-8.57%693.88M

Other payable (including interest and dividends)

21.11%2.81B

32.22%2.68B

18.36%2.29B

16.94%2.44B

31.55%2.32B

-3.70%2.03B

6.47%1.94B

4.12%2.08B

-8.71%1.76B

3.24%2.11B

-Dividend payable

0.00%224.22K

583.27%14.92M

0.00%224.22K

874.14%2.18M

-83.32%224.22K

0.00%224.22K

-Other payable

21.11%2.81B

----

17.72%2.28B

----

31.55%2.32B

----

6.36%1.93B

----

-8.71%1.76B

----

Non current liabilities due within one year

514.74%349.68M

-40.98%140.8M

-39.48%147.84M

91.04%44.49M

31.45%56.88M

366.34%238.57M

74.95%244.26M

14.20%23.29M

108.58%43.27M

-95.19%51.16M

Other current liabilities

86.22%12.76M

55.39%24.16M

38.66%15.79M

-39.27%18.25M

1.51%6.85M

-23.58%15.55M

5.56%11.39M

--30.06M

--6.75M

--20.34M

Total current liabilities

25.49%11.36B

10.36%10.63B

9.58%10.15B

1.09%10.12B

0.63%9.05B

-0.31%9.63B

6.43%9.27B

8.13%10.01B

11.94%9B

3.61%9.66B

Current liabilities

Long term loan

-42.52%746.92M

41.69%677.6M

655.47%1.05B

356.45%1.31B

171.91%1.3B

127.80%478.25M

-8.20%139.18M

67.10%287.44M

281.69%477.88M

--209.94M

Long term account payable

-65.00%91.01M

----

9.77%287.5M

----

65.13%260M

----

876.80%261.9M

----

220.81%157.45M

----

Estimate liabilities

7.45%41.07M

3.14%39.86M

-2.97%37.93M

1.37%37.92M

-0.15%38.22M

0.60%38.65M

-0.97%39.09M

-26.98%37.41M

-25.65%38.28M

-24.29%38.42M

Deferred tax liabilities

4.85%193.67M

9.29%202.08M

122.26%184.71M

108.38%184.91M

83.48%83.11M

82.11%83.11M

132.11%88.74M

Long term deferred income

71.25%176.83M

120.63%179.11M

51.01%126.12M

21.37%101.84M

19.86%103.26M

-8.85%81.18M

2.32%83.52M

47.38%83.91M

52.64%86.14M

44.05%89.06M

Lease liabilities

31.27%92.23M

9.89%105.23M

4.60%84.61M

-55.91%65.56M

-14.57%70.26M

-32.71%95.76M

-27.90%80.89M

--148.72M

--82.25M

--142.32M

Other non current liabilities

--73.25M

----

Total non current liabilities

-27.65%1.41B

37.90%1.57B

135.97%1.86B

144.05%1.96B

111.42%1.96B

91.13%1.14B

57.75%789.49M

123.48%805.04M

182.19%925.1M

220.25%594.55M

Total liabilities

16.04%12.77B

13.26%12.19B

19.50%12.02B

11.74%12.08B

10.96%11.01B

5.00%10.77B

9.22%10.06B

12.45%10.81B

18.61%9.92B

7.84%10.25B

Shareholders equity

Paid-in capital

0.24%1.75B

0.00%1.75B

Capital reserve funds

6.35%2.41B

7.08%2.39B

6.64%2.38B

4.92%2.26B

3.33%2.23B

0.02%2.16B

0.01%2.16B

Surplus reserve funds

12.70%1.15B

12.68%1.15B

18.28%1.02B

18.57%1.02B

21.60%863.79M

21.30%861.68M

Retained profit

15.70%14.42B

15.53%14.25B

16.02%13.49B

15.04%13.1B

15.86%12.46B

16.12%12.33B

18.00%11.63B

18.99%11.39B

20.69%10.75B

20.45%10.62B

Less:Treasury stock

--104.65M

----

Other composite income

37.29%-91.57M

-90.98%-119.9M

-85.38%-88.55M

-172.68%-66.8M

-429.98%-146.02M

48.18%-62.78M

-2,080.13%-47.77M

109.76%91.91M

-28.09%44.25M

-350.85%-121.16M

Shareholders equity without minority interests

12.59%19.53B

11.84%19.31B

12.05%18.58B

11.19%18.07B

11.44%17.35B

13.11%17.27B

13.40%16.58B

14.19%16.25B

14.56%15.57B

13.24%15.27B

Minority interests

60.53%650.61M

51.01%606.46M

65.36%598.52M

-17.92%513.38M

-34.72%405.28M

-30.24%401.61M

-35.32%361.94M

9.04%625.43M

12.90%620.8M

7.31%575.68M

Total shareholder equity

13.68%20.18B

12.73%19.92B

13.19%19.18B

10.11%18.58B

9.67%17.75B

11.54%17.67B

11.61%16.94B

13.99%16.88B

14.49%16.19B

13.01%15.84B

Total liabilityies and equity

14.59%32.96B

12.93%32.12B

15.54%31.19B

10.74%30.66B

10.16%28.76B

8.97%28.44B

10.71%27B

13.38%27.69B

16.02%26.11B

10.92%26.1B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q6)2023/06/30	(Q3)2023/03/31	(FY)2022/12/31	(Q9)2022/09/30	(Q6)2022/06/30	(Q3)2022/03/31	(FY)2021/12/31	(Q9)2021/09/30	(Q6)2021/06/30	(Q3)2021/03/31
Assets
Current assets
Money funds	19.30%4.39B	-27.52%2.38B	-0.90%4B	-5.69%3.18B	12.65%3.68B	4.71%3.28B	26.09%4.03B	31.30%3.37B	32.36%3.27B	15.69%3.13B
Notes receivable and accounts receivable	-0.78%7.4B	4.43%8.64B	12.08%7.21B	8.39%8.83B	8.48%7.45B	7.07%8.28B	4.77%6.43B	4.62%8.15B	5.95%6.87B	8.93%7.73B
-Notes receivable	----	--8.42M	--8.42M	----	----	----	----	----	----	----
-Accounts receivable	-0.78%7.4B	4.33%8.63B	11.95%7.2B	8.39%8.83B	8.48%7.45B	7.07%8.28B	4.77%6.43B	4.62%8.15B	5.95%6.87B	8.93%7.73B
Other receivables (including interest and dividends)	42.86%553.68M	17.80%426.38M	26.82%283.71M	23.97%371.53M	237.90%387.57M	199.12%361.94M	156.34%223.71M	47.92%299.69M	-5.85%114.7M	59.74%121M
-Dividend receivable	-93.43%223.75K	-74.51%223.75K	-74.51%223.75K	309.11%3.4M	309.11%3.4M	-79.08%877.73K	-79.08%877.73K	2.00%832.29K	2.00%832.29K	414.20%4.2M
-Accrued interest receivable	----	----	----	----	----	----	----	--15.97M	--6.33M	----
-Other receivable	44.07%553.46M	----	27.22%283.49M	----	257.23%384.16M	----	168.23%222.83M	--282.88M	-11.13%107.54M	----
Advance payment	57.66%362.09M	56.12%558.91M	81.62%500.08M	-1.90%286.05M	7.61%229.66M	0.53%358.01M	13.17%275.35M	-30.61%291.58M	-52.33%213.42M	7.17%356.12M
Inventories	14.86%4.6B	29.00%5.06B	13.11%4.5B	-0.68%4.1B	-3.04%4B	-6.35%3.92B	-2.29%3.97B	5.49%4.13B	17.08%4.13B	3.69%4.18B
Receivable financing	67.47%1.34B	104.45%1.07B	96.88%1B	-11.69%505.22M	51.33%802.25M	-9.29%524.34M	-38.55%509.19M	-32.25%572.08M	-56.68%530.12M	-54.91%578.07M
Other current assets	34.40%54.88M	341.15%154.24M	28.81%52.69M	32.19%50.28M	-9.11%40.84M	-31.72%34.96M	-52.24%40.91M	22.82%38.04M	133.99%44.93M	-28.58%51.2M
Total current assets	12.81%18.73B	9.33%18.31B	13.44%17.57B	2.82%17.32B	9.41%16.6B	3.72%16.75B	5.72%15.49B	6.85%16.85B	6.14%15.17B	3.54%16.15B
Non Current assets
Other equity investment	63.42%409.85M	62.83%409.91M	39.99%360.91M	177.03%359.7M	6.38%250.79M	10.14%251.73M	14.35%257.82M	-47.54%129.84M	-2.54%235.76M	-4.88%228.57M
Investment real estate	-6.48%13.17M	-6.41%13.39M	-6.32%13.65M	-18.92%13.85M	-18.05%14.09M	-18.37%14.31M	-18.12%14.57M	-15.78%17.08M	-18.91%17.19M	-18.35%17.53M
Long-term equity investment	54.56%1.55B	61.66%1.62B	68.45%1.66B	78.18%1.69B	6.19%1.01B	5.84%999.35M	15.86%984.93M	53.86%950.89M	125.99%947.01M	190.58%944.23M
Fixed assets	29.12%3.88B	----	29.39%3.98B	----	12.66%3.01B	----	27.14%3.08B	----	24.43%2.67B	----
Constru in process	-43.33%995.49M	----	-44.81%873.16M	----	-12.18%1.76B	----	-29.38%1.58B	----	-3.76%2B	----
Intangible assets	3.20%2.34B	1.09%2.25B	2.09%2.28B	31.53%2.25B	37.55%2.26B	55.15%2.23B	52.64%2.23B	17.90%1.71B	10.34%1.65B	4.61%1.43B
Development expenditure	2,068.06%774.1M	--689.29M	--641.35M	--108M	--35.7M	----	----	----	----	----
Goodwill	16.13%2.59B	14.83%2.46B	14.15%2.44B	18.04%2.48B	6.09%2.23B	45.54%2.14B	45.54%2.14B	42.90%2.1B	42.90%2.1B	0.00%1.47B
Long deferred expense	85.09%20.98M	54.11%20.51M	32.45%16.46M	33.11%13.99M	2.65%11.34M	69.46%13.31M	43.06%12.43M	14.96%10.51M	11.18%11.04M	-31.55%7.86M
Deferred tax assets	22.06%192.39M	6.77%153.37M	6.40%152.84M	4.03%157.61M	4.03%157.61M	4.22%143.65M	4.22%143.65M	15.66%151.51M	15.66%151.51M	18.66%137.83M
Usufruct assets	10.69%140.46M	2.20%146.53M	8.31%166.51M	-29.47%113.95M	-1.58%126.89M	-6.15%143.37M	-19.82%153.72M	--161.57M	--128.93M	--152.76M
Other non current assets	1.46%1.32B	12.41%1.2B	13.85%1.04B	119.00%1.41B	26.65%1.3B	14.56%1.07B	27.95%911.06M	24.47%642.49M	415.64%1.03B	293.35%931.65M
Total non current assets	17.01%14.23B	18.10%13.8B	18.37%13.62B	23.05%13.34B	11.20%12.16B	17.48%11.68B	18.21%11.51B	25.28%10.84B	33.23%10.93B	25.45%9.95B
Total assets	14.59%32.96B	12.93%32.12B	15.54%31.19B	10.74%30.66B	10.16%28.76B	8.97%28.44B	10.71%27B	13.38%27.69B	16.02%26.11B	10.92%26.1B
Liabilities
Current liabilities
Short term loan	22.53%1.05B	-24.91%563.01M	-23.45%947.52M	-42.51%736.19M	-38.06%858.69M	-49.59%749.83M	-12.64%1.24B	-6.39%1.28B	1.77%1.39B	84.79%1.49B
Transactional financial liabilities	--8.97M	--14.84M	--14.84M	----	----	----	----	----	----	----
Notes payable and accounts payable	28.86%6.45B	22.82%6.35B	30.59%5.9B	3.99%5.9B	0.08%5B	3.21%5.17B	0.41%4.52B	13.43%5.67B	20.98%5B	12.27%5.01B
-Notes payable	95.44%1.73B	9.57%1.36B	53.19%1.03B	-14.68%1.18B	-9.75%884.31M	26.52%1.24B	21.22%671.96M	163.74%1.38B	131.90%979.86M	44.26%981.41M
-Accounts payable	14.57%4.72B	27.01%4.99B	26.65%4.87B	9.99%4.72B	2.48%4.12B	-2.46%3.93B	-2.52%3.85B	-4.15%4.29B	8.35%4.02B	6.52%4.03B
Contract liabilities	112.06%125.33M	48.34%192.64M	23.78%146.49M	-25.32%139.27M	9.61%59.1M	-21.36%129.86M	25.38%118.34M	58.36%186.49M	-0.39%53.92M	--165.14M
Advance receipts	-4.09%1.87M	-24.34%881.24K	0.59%1.15M	-0.07%1.9M	-2.70%1.95M	70.20%1.16M	20.54%1.15M	-88.76%1.91M	24.01%2M	-98.34%684.38K
Salaries payable	11.47%215.06M	34.34%175.67M	52.72%256.88M	31.58%211.13M	64.97%192.93M	6.87%130.76M	10.59%168.21M	-18.60%160.46M	-32.70%116.95M	-18.49%122.36M
Taxs payable	-39.23%335.3M	-58.74%479.79M	-58.29%429.46M	10.88%626.83M	-11.50%551.79M	67.59%1.16B	80.07%1.03B	6.76%565.34M	73.45%623.46M	-8.57%693.88M
Other payable (including interest and dividends)	21.11%2.81B	32.22%2.68B	18.36%2.29B	16.94%2.44B	31.55%2.32B	-3.70%2.03B	6.47%1.94B	4.12%2.08B	-8.71%1.76B	3.24%2.11B
-Dividend payable	0.00%224.22K	0.00%224.22K	583.27%14.92M	0.00%224.22K	0.00%224.22K	0.00%224.22K	874.14%2.18M	-83.32%224.22K	0.00%224.22K	0.00%224.22K
-Other payable	21.11%2.81B	----	17.72%2.28B	----	31.55%2.32B	----	6.36%1.93B	----	-8.71%1.76B	----
Non current liabilities due within one year	514.74%349.68M	-40.98%140.8M	-39.48%147.84M	91.04%44.49M	31.45%56.88M	366.34%238.57M	74.95%244.26M	14.20%23.29M	108.58%43.27M	-95.19%51.16M
Other current liabilities	86.22%12.76M	55.39%24.16M	38.66%15.79M	-39.27%18.25M	1.51%6.85M	-23.58%15.55M	5.56%11.39M	--30.06M	--6.75M	--20.34M
Total current liabilities	25.49%11.36B	10.36%10.63B	9.58%10.15B	1.09%10.12B	0.63%9.05B	-0.31%9.63B	6.43%9.27B	8.13%10.01B	11.94%9B	3.61%9.66B
Current liabilities
Long term loan	-42.52%746.92M	41.69%677.6M	655.47%1.05B	356.45%1.31B	171.91%1.3B	127.80%478.25M	-8.20%139.18M	67.10%287.44M	281.69%477.88M	--209.94M
Long term account payable	-65.00%91.01M	----	9.77%287.5M	----	65.13%260M	----	876.80%261.9M	----	220.81%157.45M	----
Estimate liabilities	7.45%41.07M	3.14%39.86M	-2.97%37.93M	1.37%37.92M	-0.15%38.22M	0.60%38.65M	-0.97%39.09M	-26.98%37.41M	-25.65%38.28M	-24.29%38.42M
Deferred tax liabilities	4.85%193.67M	9.29%202.08M	9.29%202.08M	122.26%184.71M	122.26%184.71M	108.38%184.91M	108.38%184.91M	83.48%83.11M	82.11%83.11M	132.11%88.74M
Long term deferred income	71.25%176.83M	120.63%179.11M	51.01%126.12M	21.37%101.84M	19.86%103.26M	-8.85%81.18M	2.32%83.52M	47.38%83.91M	52.64%86.14M	44.05%89.06M
Lease liabilities	31.27%92.23M	9.89%105.23M	4.60%84.61M	-55.91%65.56M	-14.57%70.26M	-32.71%95.76M	-27.90%80.89M	--148.72M	--82.25M	--142.32M
Other non current liabilities	--73.25M	--73.25M	--73.25M	----	----	----	----	----	----	----
Total non current liabilities	-27.65%1.41B	37.90%1.57B	135.97%1.86B	144.05%1.96B	111.42%1.96B	91.13%1.14B	57.75%789.49M	123.48%805.04M	182.19%925.1M	220.25%594.55M
Total liabilities	16.04%12.77B	13.26%12.19B	19.50%12.02B	11.74%12.08B	10.96%11.01B	5.00%10.77B	9.22%10.06B	12.45%10.81B	18.61%9.92B	7.84%10.25B
Shareholders equity
Paid-in capital	0.24%1.75B	0.24%1.75B	0.24%1.75B	0.00%1.75B	0.00%1.75B	0.00%1.75B	0.00%1.75B	0.00%1.75B	0.00%1.75B	0.00%1.75B
Capital reserve funds	6.35%2.41B	7.08%2.39B	6.64%2.38B	4.92%2.26B	4.92%2.26B	3.33%2.23B	3.33%2.23B	0.02%2.16B	0.01%2.16B	0.01%2.16B
Surplus reserve funds	12.70%1.15B	12.70%1.15B	12.68%1.15B	18.28%1.02B	18.57%1.02B	18.57%1.02B	18.57%1.02B	21.60%863.79M	21.30%861.68M	21.30%861.68M
Retained profit	15.70%14.42B	15.53%14.25B	16.02%13.49B	15.04%13.1B	15.86%12.46B	16.12%12.33B	18.00%11.63B	18.99%11.39B	20.69%10.75B	20.45%10.62B
Less:Treasury stock	--104.65M	--104.65M	--104.65M	----	----	----	----	----	----	----
Other composite income	37.29%-91.57M	-90.98%-119.9M	-85.38%-88.55M	-172.68%-66.8M	-429.98%-146.02M	48.18%-62.78M	-2,080.13%-47.77M	109.76%91.91M	-28.09%44.25M	-350.85%-121.16M
Shareholders equity without minority interests	12.59%19.53B	11.84%19.31B	12.05%18.58B	11.19%18.07B	11.44%17.35B	13.11%17.27B	13.40%16.58B	14.19%16.25B	14.56%15.57B	13.24%15.27B
Minority interests	60.53%650.61M	51.01%606.46M	65.36%598.52M	-17.92%513.38M	-34.72%405.28M	-30.24%401.61M	-35.32%361.94M	9.04%625.43M	12.90%620.8M	7.31%575.68M
Total shareholder equity	13.68%20.18B	12.73%19.92B	13.19%19.18B	10.11%18.58B	9.67%17.75B	11.54%17.67B	11.61%16.94B	13.99%16.88B	14.49%16.19B	13.01%15.84B
Total liabilityies and equity	14.59%32.96B	12.93%32.12B	15.54%31.19B	10.74%30.66B	10.16%28.76B	8.97%28.44B	10.71%27B	13.38%27.69B	16.02%26.11B	10.92%26.1B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--
Auditor	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

000963 Huadong Medicine

Huadong Medicine Key Stats

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow